A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
Clinical trial NCT01287741 · TERMINATED
Trial details
- NCT number
- NCT01287741
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-26
- Primary completion
- 2016-04-29
- Enrollment
- 1418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.